Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Howard Liu, D.S.

Concepts (49)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms320214561.130 Why?
Lymphatic Metastasis2202129010.840 Why?
Alphapapillomavirus220212150.790 Why?
Radiosurgery4202112660.730 Why?
Papillomavirus Infections3202115200.730 Why?
Mouth Neoplasms220225780.690 Why?
Papillomaviridae3202111040.590 Why?
Carcinoma, Hepatocellular3202121630.510 Why?
Liver Neoplasms3202141710.400 Why?
Lymph Nodes1202134280.350 Why?
Head and Neck Neoplasms4202226710.290 Why?
Carcinoma, Squamous Cell4202239480.260 Why?
Neck Dissection220201920.200 Why?
Australia1202111330.160 Why?
Retrospective Studies62021741450.120 Why?
Aged, 80 and over42022576150.110 Why?
Skin Neoplasms2202154800.090 Why?
Fluorodeoxyglucose F181201819820.090 Why?
Radiopharmaceuticals1201826430.080 Why?
Disease-Free Survival1201868810.080 Why?
Carcinoma, Renal Cell1202130220.070 Why?
Aged520221613790.070 Why?
Young Adult32022557910.070 Why?
Kidney Neoplasms1202141190.070 Why?
Radiotherapy, Adjuvant2202217610.060 Why?
Neoplasm Recurrence, Local2202188960.060 Why?
Middle Aged520222121550.060 Why?
Smoking1202188820.060 Why?
Sensitivity and Specificity12018147130.060 Why?
Adult420222115230.060 Why?
Melanoma1202153570.060 Why?
Radiotherapy Dosage2202028850.050 Why?
Humans1220227250010.050 Why?
Neoplasm Staging32021109260.050 Why?
Male620223469640.040 Why?
Female620223753030.040 Why?
Lung Neoplasms12021128740.040 Why?
Follow-Up Studies12018387200.040 Why?
Carboplatin120187980.030 Why?
Clinical Trials, Phase III as Topic120187940.030 Why?
Radiation Injuries1202011650.030 Why?
Postoperative Care1201814870.020 Why?
Combined Modality Therapy1202085770.020 Why?
Patient Selection1202041960.020 Why?
Prospective Studies22021518530.020 Why?
Survival Rate12018127950.010 Why?
Practice Guidelines as Topic1202072560.010 Why?
Randomized Controlled Trials as Topic1201895890.010 Why?
Treatment Outcome12021616740.010 Why?
Liu's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (49)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.